Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis
Overview
Authors
Affiliations
Background And Aims: Intestinal fibrosis is a common complication of Crohn's disease [CD]. It is characterised by an accumulation of fibroblasts differentiating into myofibroblasts secreting excessive extracellular matrix. The potential role of the intestinal epithelium in this fibrotic process remains poorly defined.
Methods: We performed a pilot proteomic study comparing the proteome of surface epithelium, isolated by laser-capture microdissection, in normal and fibrotic zones of resected ileal CD strictures [13 zones collected in five patients]. Proteins of interests were validated by immunohistochemistry [IHC] in ileal and colonic samples of stricturing CD [n = 44], pure inflammatory CD [n = 29], and control [n = 40] subjects. The pro-fibrotic role of one selected epithelial protein was investigated through in-vitro experiments using HT-29 epithelial cells and a CCD-18Co fibroblast to myofibroblast differentiation model.
Results: Proteomic study revealed an endoplasmic reticulum [ER] stress proteins increase in the epithelium of CD ileal fibrotic strictures, including anterior gradient protein 2 homologue [AGR2] and binding-immunoglobulin protein [BiP]. This was confirmed by IHC. In HT-29 cells, tunicamycin-induced ER stress triggered AGR2 intracellular expression and its secretion. Supernatant of these HT-29 cells, pre-conditioned by tunicamycin, led to a myofibroblastic differentiation when applied on CCD-18Co fibroblasts. By using recombinant protein and blocking agent for AGR2, we demonstrated that the secretion of this protein by epithelial cells can play a role in the myofibroblastic differentiation.
Conclusions: The development of CD fibrotic strictures could involve epithelial ER stress and particularly the secretion of AGR2.
Essential roles of the unfolded protein response in intestinal physiology.
Hetz C, Silva-Aguero J, Ellerby L eGastroenterology. 2025; 2(4):e100129.
PMID: 39944266 PMC: 11770430. DOI: 10.1136/egastro-2024-100129.
Pietz T, Gupta S, Schlaffner C, Ahmed S, Steen H, Renard B Bioinformatics. 2024; 40(Suppl 2):ii70-ii78.
PMID: 39230699 PMC: 11373339. DOI: 10.1093/bioinformatics/btae389.
Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?.
Bidooki S, Navarro M, Fernandes S, Osada J Curr Issues Mol Biol. 2024; 46(4):3134-3163.
PMID: 38666927 PMC: 11049379. DOI: 10.3390/cimb46040197.
Zou M, Liang Q, Zhang W, Zhu Y, Xu Y Front Genet. 2023; 14:1270085.
PMID: 37860672 PMC: 10583552. DOI: 10.3389/fgene.2023.1270085.
Wang J, Bai M, Zhang C, An N, Wan L, Wang X Acta Pharmacol Sin. 2023; 44(12):2469-2478.
PMID: 37580493 PMC: 10692176. DOI: 10.1038/s41401-023-01143-1.